Phase 3 Randomized Trial Support High Intensity Conditioning with Myeloablative Regimens in AML

Navneet Majhail, MD Director of the Blood and Marrow Transplant Program Cleveland Clinic discusses a Phase 3 Randomized Trial Support High Intensity Conditioning with Myeloablative Regimens in AML